← Leaderboards
Jeffrey S Elmendorf
Indiana Univ-Purdue Univ At Indianapolis
$7,573,683
Attributed
$7,573,683
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $620.7K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,573,683 · 7
By mechanism
P30$3,920,586 · 3
R01$3,628,097 · 3
R13$25,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Indiana Univ-Purdue Univ At Indianapolis
Same institution · by research overlap
- Min You$9,539,242
Others in their field
Top investigators on “Diabetes Mellitus”
- Jeffrey P Krischer · University Of South Florida$608,226,434
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$177,347,135
- John M Lachin · George Washington University$155,262,668
- David M Nathan · Massachusetts Institute Of Technology$142,806,023
- Judith S Hochman · New York University School Of Medicine$100,149,457
- Jose A Luchsinger · Columbia University Health Sciences$75,551,718
Research focus
Diabetes MellitusInvestigationLeadFundingInterestResearch PersonnelProgramsInstitutionAreaMissionGlucose TransporterMetabolic DiseasesCommunitiesCollaborationsMemberObesityDisciplineGlucose TransportCharacteristicsIndianaInsulinEventBaseFostering
Grant awards (24)
Pilot & Feasibility Program$435,306
P30 · FY2025 · DK · contact PI
Pilot & Feasibility Progam$469,878
P30 · FY2024 · DK · contact PI
Molecular Metabolism: From Cell Biology to Systems Physiology$25,000
R13 · FY2024 · DK · contact PI
Pilot & Feasibility Progam$469,878
P30 · FY2023 · DK · contact PI
Pilot & Feasibility Progam$469,878
P30 · FY2022 · DK · contact PI
Pilot & Feasibility Progam$469,878
P30 · FY2021 · DK · contact PI
Pilot & Feasibility Progam$469,878
P30 · FY2020 · DK · contact PI
Cholesterol Toxicity as a Promising Target for Diabetes Prevention$393,543
R01 · FY2019 · DK · contact PI
P&F Program$227,178
P30 · FY2019 · DK · contact PI
Cholesterol Toxicity as a Promising Target for Diabetes Prevention$388,254
R01 · FY2018 · DK · contact PI
P&F Program$227,178
P30 · FY2018 · DK · contact PI
P&F Program$227,178
P30 · FY2017 · DK · contact PI
P&F Program$227,178
P30 · FY2016 · DK · contact PI
P&F Program$227,178
P30 · FY2015 · DK · contact PI
Mechanisms of Membrane-Based Insulin Resistance & Therapeutic Reversal Strategies$328,285
R01 · FY2012 · DK · contact PI
Mechanisms of Membrane-Based Insulin Resistance & Therapeutic Reversal Strategies$328,285
R01 · FY2011 · DK · contact PI
Mechanisms of Membrane-Based Insulin Resistance & Therapeutic Reversal Strategies$365,904
R01 · FY2010 · DK · contact PI
Mechanisms of Membrane-Based Insulin Resistance & Therapeutic Reversal Strategies$40,000
R01 · FY2010 · DK · contact PI
Mechanisms of Membrane-Based Insulin Resistance & Therapeutic Reversal Strategies$369,600
R01 · FY2009 · DK · contact PI
CHROMIUM ENHANCES INSULIN & GLUT4 ACTION VIA LIPID RAFTS$270,764
R01 · FY2008 · AT · contact PI
CHROMIUM ENHANCES INSULIN & GLUT4 ACTION VIA LIPID RAFTS$276,291
R01 · FY2007 · AT · contact PI
CHROMIUM ENHANCES INSULIN & GLUT4 ACTION VIA LIPID RAFTS$276,291
R01 · FY2006 · AT · contact PI
CHROMIUM ENHANCES INSULIN &GLUT4 ACTION VIA LIPID RAFTS$282,940
R01 · FY2005 · AT
CHROMIUM ENHANCES INSULIN &GLUT4 ACTION VIA LIPID RAFTS$307,940
R01 · FY2004 · AT